By Mary Stuart
The acquisition of Ardian Inc. by Medtronic PLC announced in November was, by many measures, remarkable. [See Deal] Medtronic offered $800 million for the 89% of the company that it didn't already own, with a potential upside of $500 million more in milestone payments. The price was one of highest ever paid for a venture capital-backed medical device company, all the more surprising since Ardian's technology is still at the pre-commercialization stage
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?